Abstract
To examine whether renal cell carcinoma displays altered CD44 expression we performed reverse transcription‐polymerase chain reaction (RT‐PCR) analysis of CD44 in 38 specimens from renal cancer, normal kidney and metastases of 19 patients and 6 renal cancer cell lines. To detect the CD44 variants, we utilized the RT‐PCR Southern blot method. One out of 19 (5.3%) renal cancer specimens expressed a larger molecular weight band than 1 kb by RT‐PCR analysis, in contrast to previous findings in colon and breast cancer. The band patterns in RT‐PCR were different in 14/17 (82.4%) cases between normal kidney and tumors, and a band of about 700 bp was especially marked in 12/17 (70.6%) tumor specimens and 4/6 (66.7%) cell lines. By cloning and sequencing of the 700 bp band, we found that this variant is identical to the CD44 variant sharing only exon v10. Examination by Northern blot analysis has revealed that all tumors express a higher level of CD44 mRNA than paired normal kidneys. These findings suggested that the CD44 variants sharing exon v10 play some role in renal cancer.
Keywords: CD44, Exon v10, Renal cancer, RT‐PCR
Full Text
The Full Text of this article is available as a PDF (712.4 KB).
REFERENCES
- 1. ) Glaves , D.Correlation between circulating cancer cells and incidence of metastasis . Br. J. Cancer , 48 , 665 – 673 ( 1983. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. ) Jalkanen , S. , Bargatze , R. F. , Herron , L. R. and Butcher , E. C.A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man . Eur. J. Immunol. , 16 , 1195 – 1202 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Jalknen , S. , Bargatze , R. F. , Toyos , J. D. L. and Butcher , E. C.Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85–95‐kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells . J. Cell Biol. , 105 , 983 – 990 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. ) Huet , S. , Groux , H. , Caillou , B. , Valentin , H. , Prieur , A. M. and Bernard , A.CD44 contributes to T cell activation . J. Immunol. , 143 , 798 – 803 ( 1989. ). [PubMed] [Google Scholar]
- 5. ) Shimizu , Y. , Van Seventer , G. A. , Siraganian , R. , Wahl , L. and Shaw , S.Dual role of the CD44 molecule in T cell adhesion and activation . J. Immunol. , 143 , 2457 – 2463 ( 1989. ). [PubMed] [Google Scholar]
- 6. ) St. John , T. , Meyer , J. , Iderza , R. and Gallatin , W. M.Expression of CD44 confers a new adhesive phenotype on transfected cell . Cell , 60 , 45 – 52 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Caner , W. G. and Wayner , E. A.Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells . J. Biol. Chem. , 263 , 4193 – 4201 ( 1988. ). [PubMed] [Google Scholar]
- 8. ) Jackson , D. G. , Buckley , J. and Bell , J. I.Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracelllar domain . J. Biol. Chem. , 267 , 4734 – 4739 ( 1992. ). [PubMed] [Google Scholar]
- 9. ) Screaton , G. R. , Bell , M. V. , Jackson , D. G. , Cornells , F. B. , Gerth , U. and Bell , J. I.Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons . Proc. Natl. Acad. Sci. USA , 89 , 12160 – 12164 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. ) Tolg , C. , Hofmann , M. , Herrlich , P. and Ponta , H.Splicing choice from ten variant exons establishes CD44 variability . Nucleic Acids Res. , 21 , 1225 – 1229 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. ) Matsumura , Y. and Tarin , D.Significance of CD44 gene products for cancer diagnosis and disease evaluation . Lancet , 340 , 1053 – 1058 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Kuppner , M. C. , Meir , E. V. , Gauthier , T. H. , Hamou , M.‐F. and Tribolet , N.Differential expression of the CD44 molecules in human brain tumors . Int. J. Cancer , 50 , 572 – 577 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Günthert , U. , Hofmann , M. , Rudy , W. , Reber , S. , Zoller , M. , Haußmann , I. , Siegfried , M. , Wenzel , A. , Ponta , H. and Herrich , P.A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells . Cell , 65 , 13 – 24 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Matsumura , Y. , Hanbury , D. , Smith , J. and Tarin , D.Non‐invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells . Br. Med. J. , 308 , 619 – 624 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. ) Fujita , N. , Yaegashi , N. , Ide , Y. , Nakamura , M. , Ishikawa , I. and Yajima , A.Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymphvascular space involvement of cancer cells . Cancer Res. , 54 , 3922 – 3928 ( 1994. ). [PubMed] [Google Scholar]
- 16. ) Arch , R. , Wirth , K. , Hofmann , M. , Ponta , H. , Matzku , S. , Herrlich , P. and Zöller , M.Participation in normal immune responses of a metastasis‐inducing splice variant of CD44 . Science , 257 , 682 – 685 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Rudy , W. , Hofmann , M. , Schwartz , A. R. , Zoller , M. , Heider , K. H. , Ponta , H. and Herrlich , P.The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior . Cancer Res. , 53 , 1262 – 1268 ( 1993. ). [PubMed] [Google Scholar]
- 18. ) Seiter , S. , Arch , R. , Reber , S. , Komitowski , D. , Hofmann , M. , Ponta , H. , Herrlich , P. , Matzku , S. and Zoller , M.Prevention of tumor metastasis formation by anti‐variant CD44 . J. Exp. Med. , 177 , 443 – 455 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. ) Birch , M. , Mitchell , S. and Hart , I. R.Isolation and characterization of human melanoma cell variants expressing high and low level of CD44 . Cancer Res. , 51 , 6660 – 6667 ( 1991. ). [PubMed] [Google Scholar]
- 20. ) Heider , K. H. , Dammrich , J. , Skroch‐Angel , P. , Muller‐Hermelink , H.‐K. , Vollmers , H. P. , Herrlich , P. and Ponta , H.Differential expression of CD44 splice variants in intestinal‐ and diffuse type human gastric carcinomas and normal gastric mucosa . Cancer Res. , 53 , 4197 – 4203 ( 1993. ). [PubMed] [Google Scholar]
- 21. ) Tanabe , K. K. , Ellis , L. M. and Saya , H.Expression of CD44R1 adhesion molecule in colon carcinomas and metastases . Lancet , 341 , 725 – 726 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 22. ) Heider , K. H. , Hoffman , M. , Hors , E. , van den Berg , F. , Ponta , H. , Herrlich , P. and Pals , S. T.A human homologue of rat metastasis‐associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps . J. Cell Biol. , 120 , 227 – 233 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. ) Marckay , C. R. , Terpe , H. A. , Stauder , R. , Marston , W. L. , Stark , H. and Gunthert , U.Expression and modulation of CD44 variant isoforms in humans . J. Cell Biol. , 124 , 71 – 82 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. ) Hamao , T. , Kanayama , H. , Kan , M. , Takigawa , H. and Kagawa , S.Serum levels and gene expressions of interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6) and tumor necrosis factor‐α (IL‐α) in human renal cell carcinomas . Jpn. J. Urol. , 85 , 563 – 570 ( 1994. ). [DOI] [PubMed] [Google Scholar]